Results 41 to 50 of about 339 (90)

The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum. [PDF]

J Cardiovasc Pharmacol, 2022
Levijoki J, Pollesello P, Pollesello P, Grossini E, Papp Z.   +4 more
europepmc   +1 more source

Efficacy of levosimendan for acute decompensated heart failure with preserved ejection fraction in the elderly: a single-center retrospective analysis. [PDF]

BMC Cardiovasc Disord
Xu X, Lv F, Xu C, Lai X.
europepmc   +1 more source

The effect of levosimendan on the right ventricular function in patients with right ventricular dysfunction undergoing mitral valve surgery. [PDF]

Ann Card Anaesth, 2023
Bharathi KS, Pruthi G, Dhananjaya M, Simha PP.   +3 more
europepmc   +1 more source

Clinical analysis of atrial fibrillation after levosimendan treatment for acute decompensated heart failure: A propensity score-matched study. [PDF]

Medicine (Baltimore)
Chen B, Chen Z, Gao Q, Li Q, Yang T.
europepmc   +1 more source

Levosimendan: efficacy and safety in pediatric heart failure treatment. [PDF]

Rev Assoc Med Bras (1992)
Dündar MA, Yılmaz M, Argun M.
europepmc   +1 more source

Levosimendan improves central haemodynamic status and gas exchange in a model of ischaemic cardiac arrest: A large animal study. [PDF]

Eur J Anaesthesiol
Rysz S, Al-Saadi J, Campoccia Jalde F, Nyman J, Lundberg J, Jonsson Fagerlund M, Djärv T.   +6 more
europepmc   +1 more source

Clinical efficacy and hemodynamic effects of levosimendan in cardiac surgery patients after surgery. [PDF]

J Cardiothorac Surg
Zhao M, Hou Y, Yuan M, Ma S, Yue Y.
europepmc   +1 more source

Levosimendan Pretreatment Attenuates Mesenteric Artery Ischemia/Reperfusion Injury and Multi-Organ Damage in Rats. [PDF]

Int J Mol Sci
Matković Z, Gajić Bojić M, Maličević U, Krivokuća A, Mandić-Kovačević N, Uletilović S, Amidžić L, Jovičić S, Barudžija M, Stojiljković MP, Gajanin R, Bolevich S, Škrbić R.   +12 more
europepmc   +1 more source

Population Pharmacokinetics of Levosimendan and its Metabolites OR-1855 and OR-1896 in Critically Ill Adults, Neonates and Infants on Veno-Arterial ECMO. [PDF]

Clin Pharmacokinet
Bertin S, Guidi M, Haefliger D, Thoueille P, Bardinet C, Decosterd LA, Perez MH, Giraud R, Assouline B, Schneider A, Buclin T, Livio F.   +11 more
europepmc   +1 more source

Levosimendan for postoperative subclinical heart failure after noncardiac surgery: a randomized, double-blinded, phase III trial. [PDF]

Nat Commun
Reiterer C, Kabon B, Taschner A, Graf A, Adamowitsch N, Horvath K, Emler D, Zotti O, Hantakova N, Hochreiter B, Fraunschiel M, Clement T, Fleischmann E.   +12 more
europepmc   +1 more source